<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Publication on Michael’s Domain</title><link>https://jeltsch.org/en/tags/publication/</link><description>Recent content in Publication on Michael’s Domain</description><generator>Hugo</generator><language>en-us</language><copyright>Copyright © 2002 - 2026 Michael Jeltsch.</copyright><lastBuildDate>Fri, 24 Jul 2026 00:18:18 +0300</lastBuildDate><atom:link href="https://jeltsch.org/en/tags/publication/index.xml" rel="self" type="application/rss+xml"/><item><title>1000+ citations</title><link>https://jeltsch.org/en/1000_citations/</link><pubDate>Wed, 15 May 2019 00:00:00 +0000</pubDate><guid>https://jeltsch.org/en/1000_citations/</guid><description>&lt;p&gt;The first among my publications to brake the 1000 citations-barrier was 
 &lt;a href="https://doi.org/10.1083/jcb.200302047" target="_blank" rel="noopener noreferrer nofollow"&gt;Gerhardt et al. 2003&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
. With the &amp;ldquo;tip cell concept&amp;rdquo;, it set a paradigm for vascular biology research: Not all endothelial cells are equal and the tip cell is a specialized cell that marks the forefront of the angiogenic sprout. However, my contribution was limited (number 7 out of 11 authors): I produced most of the proteins that were needed for the study. This spring, 
 &lt;a href="https://doi.org/10.1126/science.276.5317.1423" target="_blank" rel="noopener noreferrer nofollow"&gt;Jeltsch et al. 1997&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
 crossed the first time the 1000-citation mark. The paper describes a mouse, that overexpresses VEGF-C in the skin. It is the first ever in-vivo demonstration of a lymphangiogenic growth factor. Although not setting any paradigm, it marks the start of the 
 &lt;a href="https://web.archive.org/web/20160305010215/http://www.nature.com/focus/angiogenesis/classics/vegf.html" target="_blank" rel="noopener noreferrer nofollow"&gt;molecular era in lymphatic research&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
. What percentage of papers achieve 1000+ citations? That differs between disciplines, but e.g. according to 
 &lt;a href="https://en.wikipedia.org/wiki/Citation_impact" target="_blank" rel="noopener noreferrer nofollow"&gt;https://en.wikipedia.org/wiki/Citation_impact&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
 on average it is less than 1 in 4000. Compare this to the average paper, which receives 7.8 citations. And even this average is heavily influenced by a few highly-cited papers (
 &lt;a href="https://commons.wikimedia.org/wiki/File:Journal_impact_factor_Nature_Plos_One.png" target="_blank" rel="noopener noreferrer nofollow"&gt;similar to the Impact Factor&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
). The median number of citations is 4, meaning that about half of all papers have less than 4 citations (see 
 &lt;a href="http://www.scottbot.net/HIAL/index.html@p=22108.html" target="_blank" rel="noopener noreferrer nofollow"&gt;here&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
).&lt;/p&gt;</description></item><item><title>Best paper award</title><link>https://jeltsch.org/en/best_paper_award/</link><pubDate>Fri, 01 May 2015 00:00:00 +0000</pubDate><guid>https://jeltsch.org/en/best_paper_award/</guid><description>&lt;p&gt;[&lt;/p&gt;
&lt;p&gt;![](/sites/](
 &lt;a href="http://www.med.helsinki.fi/english/news/2015/20150505_Jeltsch.html%29We" target="_blank" rel="noopener noreferrer nofollow"&gt;http://www.med.helsinki.fi/english/news/2015/20150505_Jeltsch.html)We&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
 have won Circulation’s 2014 &lt;em&gt;Best Paper Award&lt;/em&gt; in the category of Basic Science. &lt;em&gt;Circulation&lt;/em&gt; is the leading cardiology journal and the organ of the 
 &lt;a href="http://www.heart.org" target="_blank" rel="noopener noreferrer nofollow"&gt;American Heart Association&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
. Already when we published the paper (titled [/files/files/Jeltsch%20et%20al.%20-%202014%20-%20CCBE1%20Enhances%20Lymphangiogenesis%20via%20A%20Disintegrin.pdf&amp;quot;&amp;gt;“CCBE1 Enhances Lymphangiogenesis via A Disintegrin and Metalloprotease With Thrombospondin Motifs-3–Mediated Vascular Endothelial Growth Factor-C Activation”](/sites/&amp;lt;?php print $_SERVER[)), it was clear that it provided a major overhaul of our understanding of the 
 &lt;a href="http://en.wikipedia.org/wiki/Vascular_endothelial_growth_factor_C" target="_blank" rel="noopener noreferrer nofollow"&gt;VEGF-C growth factor&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
 and it got featured by 
 &lt;a href="http://openheart.circulationjournal.org/2014/05/michael-jeltsch-phd-and-kari-alitalo-md.html" target="_blank" rel="noopener noreferrer nofollow"&gt;Open Heart&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
. The article manages to provide multiple new insights:&lt;/p&gt;</description></item></channel></rss>